Table 45.
Index thrombotic event and anticoagulation therapy regimen and laboratory parameters at time of anticoagulation initiation.
| Characteristic | n (%), unless otherwise specified |
|---|---|
| Index thrombotic event | |
| Pulmonary embolus | 24 (41.4) |
| Isolated DVT | 11 (22.9) |
| DVT with pulmonary embolus | 10 (17.2) |
| Portal or mesenteric thrombus | 3 (5.2) |
| Intracranial thrombus | 3 (5.2) |
| DVT with portal or mesenteric thrombus | 5 (8.6) |
| DVT with PE and portal or mesenteric thrombus | 1 (1.7) |
| DVT with PE and intracranial thrombus | 1 (1.7) |
| Anticoagulation Regimen | |
| LMWH | 5 (8.6) |
| LMWH, bridged to warfarin | 10 (17.2) |
| LMWH, bridged to warfarin, then NOAC | 6 (10.3) |
| LMWH, bridged to NOAC | 9 (15.5) |
| Warfarin | 11 (19.0) |
| Warfarin, switched to NOAC | 5 (8.6) |
| NOAC | 12 (20.7) |
| Laboratory parameters at time of thrombosis, mean (SD) | |
| Hemoglobin | 120.8 (23.1) |
| Platelet count | 280.5 (119.2) |
| INR | 2.7 (11.3) |
| aPTT | 30.6 (11.6) |
| ESR∗ | 30.8 (27.8) |
| CRP∗ | 31.8 (40.8) |